Peter Fedichev

Peter co-founded two biotech companies, Quantum Pharmaceuticals, a drug discovery company, and Gero, a longevity startup that started out as a project of Quantum Pharmaceuticals and is focused on developing therapies that will extend a healthy human lifespan.

Peter’s scientific background lies in the field of condensed matter physics, biophysics, and bioinformatics. He was top-2 cited Russian physicist under 35 and has conducted research at Kurchatov Institute, one of the leading science government agencies in Russia, AMOLF, an academic institute for fundamental physics in the Netherlands, and the University of Innsbruck. Peter earned his M.S. in theoretical physics from the Moscow Institute of Physics and Technology and his Ph.D. from the University of Amsterdam and currently has over 70 publications in peer-reviewed journals.

Peter Fedichev is the Founder and CEO at Gero, based in Europe. With a background in Biotechnology, Peter Fedichev has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.